BIO campaign gathers pharma partners to lobby Congress against superbugs

Beth Snyder Bulik

August 29, 2019

Merck, Novo Holdings and several smaller drug developers are partnering with the Biotechnology Innovation Organization (BIO) trade group in a new initiative to spur research and development in the fight against superbugs…

NPR

How the pandemic gave power to superbugs

Antibiotics cannot cure COVID. They don’t help a bit. And yet, new data shows that, during the pandemic, COVID patients…

The World Needs New Antibiotics. The Problem Is, No One Can Make Them Profitably.

The push for antibiotics to fight fast-evolving superbugs is snagging on a broken business model. Six startups have won Food and Drug…

Fighting AMR with a value and subscription model

The recent reintroduction of the Pasteur Bill seeks to address the global threat that antimicrobial-resistant (AMR) infections pose, one subscription…

Scientists use AI to find new antibiotics, but can they climb out of the ‘valley of death’ to the clinic?

Developing a new antibiotic can take as long as 15 years. But in as few as two, the target bug…

Name
First Last
Email
Zipcode
Organization
Title
Email
This field is for validation purposes and should be left unchanged.

Fierce Pharma

BIO campaign gathers pharma partners to lobby Congress against superbugs

Beth Snyder Bulik

August 29, 2019

More

NPR

How the pandemic gave power to superbugs

Wall Street Journal

The World Needs New Antibiotics. The Problem Is, No One Can Make Them Profitably.

Pharmaceutical Technology

Fighting AMR with a value and subscription model

Fierce Biotech

Scientists use AI to find new antibiotics, but can they climb out of the ‘valley of death’ to the clinic?

Sign up for the latest on fighting AMR